Billionaires are investing heavily in a cutting-edge tech company specializing in the creation of genetically engineered monkey organs, with hopes that lab-grown human parts could soon follow.
Hosted on MSN
'Headless' human bodies could replace lab animals for scientific testing: 'A great source of organs'
Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with living “organ sacks” grown from human cells. R3 Bio, a billionaire-backed biotech startup, is ...
Organoids, organs-on-a-chip, and machine learning technologies have improved dramatically in recent years, but have they come far enough to replace animal research? Additionally, despite attempts to ...
In April of this year, the Food and Drug Administration (FDA) announced a new roadmap that aims to replace animal testing in the development of new drugs with more human-relevant methods. The goal is ...
In April 2025, the US Food and Drug Administration (FDA) announced plans to phase out certain animal testing requirements, explicitly promoting organoids as superior, human-based alternatives for drug ...
Researchers at the University of California, Irvine have developed a 3D human colon model integrated with bioelectronics to aid in colorectal cancer research and drug discovery. The "3D in vivo ...
Typically, bone marrow research relies heavily on animal models and oversimplified cell cultures in the laboratory. Now, researchers from the Department of Biomedicine at the University of Basel and ...
‘Headless’ human bodies could replace lab animals for scientific testing: ‘A great source of organs’
Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with living “organ sacks” grown from human cells. R3 Bio, a billionaire-backed biotech startup, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results